Zacks Investment Research
16 Oct 2026, 09:16 UTC · 1h ago
Impact · against what's priced in
SkinHealth Systems' reverse stock split provides a temporary technical lift by removing the immediate threat of Nasdaq delisting, but fundamental deterioration remains severe. The expected massive EPS decay and revenue contraction likely offset the compliance gain for long-term investors.
No priced-in read yet
What the story claims
3 claims · scored −1 bearish … +1 bullish · 1 new · 2 priced in
SkinHealth Systems is expected to report a quarterly loss of $1.35 per share, a year-over-year decrease of 1400%.
Priced inanalysis of upcoming report expectations
So whatThe massive EPS decay suggests a severe deterioration in fundamentals heading into the next print.
More negative than 90% of claims this week
SkinHealth Systems completed a 1-for-20 reverse stock split effective October 14, 2026, reducing Class A shares from 130.3 million to 6.5 million.
Continue reading
5 related stories
The 1-for-20 reverse stock split restores Nasdaq compliance by lifting the share price above $1.00, though this technical win is countered by an expected quarterly loss of $1.35 per share and a 5% revenue decline.
Read from the article alone
No priced-in read yet
The article mentions DHR only as an industry peer and provides no material updates regarding its specific operations or financial outlook.
Read from the article alone
Scored by the NIS engine · methodology.
Neweffective Oct. 14, 2026
So whatThe action restores Nasdaq compliance by lifting the share price above $1.00, removing immediate delisting risk.
More positive than 68% of claims this week
Revenues for SkinHealth Systems are expected to be $67.18 million, representing a 5% decline from the prior year's quarter.
Priced inanalysis of upcoming report expectations
So whatA 5% top-line contraction combined with widening losses pressures the company's valuation multiple.
More negative than 68% of claims this week
Which stocks this story touches
More positive than 73% of ticker scores this week
The stock closed 3% higher with a positive monthly return and holds a Zacks Rank #2 (Buy).
More positive than 64% of ticker scores this week
The stock price rose 9% following a reverse stock split to regain Nasdaq compliance, though upcoming earnings expectations remain very poor.
Free · No account
Get a free daily PDF briefing — the last 24 hours of news, with summaries and the market-impact score for each story, delivered an hour before the open.
We’ll watch
Pre-filled from this story — remove any you don’t want. Add more tickers & tags or fine-tune your watchlist anytime — every email has an edit link, no account needed.
Free forever · one email a day, max · unsubscribe in one click.How it works
PRNewsWire
10h ago
—
DHR hasn't traded since this ran. Last close $231.50 (Oct 15); the reaction starts at the next open.
DHR chart →—
SKIN hasn't traded since this ran. Last close $12.60 (Oct 15); the reaction starts at the next open.
SKIN chart →
